Related Experiment Video
Updated: Jun 17, 2025
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
It Is Time for a Simplified Approach to Hepatitis B Elimination.
Douglas Dieterich1, Camilla Graham2, Su Wang3
1Division of Liver Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Gastro Hep Advances
|August 12, 2024
Summary
Simplifying Hepatitis B virus (HBV) care guidelines can improve diagnosis and treatment, reducing liver cancer risk. This expert panel developed a streamlined algorithm for better HBV management globally.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis B virus (HBV) infection affects millions globally, with complex current guidelines hindering diagnosis and management.
- Antiviral therapy reduces liver complications, but guideline complexity creates barriers to care and exacerbates health disparities.
- A streamlined approach is needed to facilitate HBV intervention and treatment, particularly in primary care.
Purpose of the Study:
- To achieve consensus on a simplified algorithm for Hepatitis B virus (HBV) care.
- To encourage the implementation of HBV intervention and treatment strategies.
- To address the complexity of existing guidelines and improve patient outcomes.
Main Methods:
- A global expert panel of 8 liver and infectious disease specialists convened in January 2021.
- The panel aimed to reach consensus on a streamlined algorithm for HBV care.
- The focus was on facilitating the implementation of HBV intervention and treatment.
Main Results:
- A comprehensive perspective on screening optimization, diagnostic workup, treatment, and monitoring was developed.
- A streamlined visual treatment algorithm for risk stratification and management of HBV patients was created.
- The algorithm is designed for adaptability across various healthcare settings.
Conclusions:
- Simplifying HBV care guidelines is crucial for achieving health equity.
- Streamlined guidelines can help address the public health threat of HBV.
- Simplified approaches are essential for HBV elimination efforts.
Related Concept Videos
01:23Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
01:10Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
36
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
36
01:16Hepatic Drug Excretion: Influencing Factors
104
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
104
01:06Drug Elimination: The Concept of Clearance
2.6K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
2.6K